Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors
Lei Zhou(Io Therapeutics (United States)), Laura Bohn(Scripps Research Institute), Stephen R. Slauson(University of Kansas), Cullen L. Schmid(Scripps Research Institute), Thomas E. Prisinzano(University of Kansas), Michael D. Cameron(Io Therapeutics (United States)), John M. Streicher(University of Arizona), Franck Madoux(Scripps Research Institute), Edward L. Stahl(University of South Florida), Angela M. Phillips(Io Therapeutics (United States)), Kevin J. Frankowski(University of Kansas), Jeffrey Aubé(University of Kansas), Peter Hodder(Scripps Research Institute), Kimberly M. Lovell(Io Therapeutics (United States))
Cited by 148
Related Papers
Diverse Actions of Ovarian Steroids in the Serotonin Neural System
|Frontiers in Neuroendocrinology|2002|485
Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice.
|PubMed|2002|268
Differential Mechanisms of Morphine Antinociceptive Tolerance Revealed in βArrestin-2 Knock-Out Mice
|Journal of Neuroscience|2002|243
Serotonin, But Not <i>N</i> -Methyltryptamines, Activates the Serotonin 2A Receptor Via a β-Arrestin2/Src/Akt Signaling Complex <i>In Vivo</i>
|Journal of Neuroscience|2010|171
MAPK-Activated Protein Kinase-2 in Cardiac Hypertrophy and Cyclooxygenase-2 Regulation in Heart
|Circulation Research|2010|123